Listed Mainboard IPO CORONA

Corona Remedies IPO GMP & Allotment

Corona Remedies is a Mainboard IPO with a price band of Rs 1008.00 to Rs 1062.00 that listed on 15 Dec 2025 at a listing gain of +38.42%. Track its full GMP history, subscription data and listing details here.

IPO Price Band
₹1008.00 - ₹1062.00
Lot Size
TBA
Bidding Closes
TBA
Listing Date
15 Dec 2025
Quick Answer & Highlights

Corona Remedies IPO GMP Today & Key Takeaways

Last updated: 08 Feb 2026

Corona Remedies IPO officially listed on 15 Dec 2025 at Rs 1470.00, delivering a +38.42% listing gain compared to its issue price of Rs 1062.00. Pre-listing, its final recorded Grey Market Premium (GMP) was ₹408.

Key Metric Figure Status / Context
Current GMP ₹408 +38.42% vs upper band (08 Feb 2026)
Est. Listing Price ₹1470.00 +38.42% Est. Listing Gain
Price Band ₹1008.00 - ₹1062.00 Mainboard IPO
Retail Minimum Investment TBA 1 Lot (TBA)
Bidding Window 08 Dec 2025 – TBA Listed
Allotment & Listing Dates Allotment: TBA Listing: 15 Dec 2025
Will you apply for this IPO?
Is this GMP accurate?
IPO Details

Complete IPO information

Corona Remedies IPO Details and Specifications
IPO Open Date 08 Dec 2025
IPO Close Date TBA
IPO Price Band ₹1008.00 - ₹1062.00
Lot Size TBA
Current GMP ₹408
Estimated Listing Gain +38.42%
Issue Size -
Fresh Issue -
Issue Type Mainboard
IPO Listing NSE, BSE
Retail Quota TBA
Registrar TBA
Overall Subscription TBA
Minimum Investment TBA
DRHP Draft Prospectus PDF
RHP Draft Prospectus -
Analysis

IPO Snapshot & Investor Takeaways

The latest recorded Grey Market Premium for Corona Remedies stands at ₹408, implying an estimated listing gain of around 38.42% over the issue price if it holds until listing. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.

Mainboard IPOs list on the main platform of BSE/NSE, typically involve larger issue sizes, and draw participation across retail, HNI and institutional (QIB) investor categories.

Timeline

IPO roadmap at a glance

✓
Bidding Opens 08 Dec 2025
✓
Bidding Closes TBA
✓
Allotment TBA
✓
Listing 15 Dec 2025
Corona Remedies IPO Timeline and Important Dates Schedule
Event / Milestone Scheduled Date Status
Bidding Opens 08 Dec 2025 Completed
Bidding Closes TBA Completed
Allotment TBA Completed
Listing 15 Dec 2025 Completed
Market Lot

Application size breakdown

Corona Remedies IPO Market Lot & Application Breakdown
Category Lots Shares Amount
Retail Minimum 1 Lot - -
Retail Maximum - - -
S-HNI Minimum - - -
S-HNI Maximum - - -
B-HNI Minimum - - -
Swipe to see more →
Fund Utilization

Objects of the Issue & Official Documents

Issue Notes

Important takeaways before applying

Additional note

Listed at 1470.0 for 38.42% gains

Analysis

కరోనా నివారణలు IPO Dates

Particular Dates
IPO Open Date 08 Dec 2025
IPO Close Date -
Basis of Allotment -
Refunds -
Credit to Demat Account -
IPO Listing Date 15 Dec 2025

Note: The timeline for కరోనా నివారణలు IPO is tentative and subject to change.

Analysis

కరోనా నివారణలు Objects of the Issue & Utilisation of Proceeds

To Be Updated Soon

Analysis

కరోనా నివారణలు Company Financials

To Be Updated Soon

Analysis

కరోనా నివారణలు Company Valuation – FY2026

To Be Updated Soon

Analysis

కరోనా నివారణలు IPO Peer Group Comparison

To Be Updated Soon

Comparison

Compare Corona Remedies IPO with similar IPOs

FAQ

Corona Remedies IPO FAQs

Corona Remedies IPO GMP today is Rs 408. Investors can use this GMP along with price band and subscription status for a better IPO review.
Based on the latest Grey Market Premium (GMP) of Rs 408 and an issue price of Rs 1062, the estimated listing price for Corona Remedies IPO is Rs 1470.00 (approx 38.42% listing gain). Actual listing price is determined by market demand on the listing day.
Corona Remedies IPO price band is Rs 1008.00 to Rs 1062.00. Check the latest issue price, lot size and GMP together before applying.
Corona Remedies IPO open date is 08 Dec 2025, close date is TBA, and listing date is 15 Dec 2025.
Corona Remedies IPO lot size is TBA. The minimum retail investment is TBA.
Corona Remedies is classified as a Mainboard IPO. This helps investors quickly understand the issue category and exchange segment.
Corona Remedies IPO subscription status currently shows Subscription data is currently awaited.
In our empirical study of 117 Indian IPO listings, positive GMP was followed by a positive listing gain 69.8% of the time. However, as an exact forecast, the median variation between GMP-implied gain and actual listing price was 8 percentage points. GMP reflects informal market sentiment and should always be evaluated alongside company valuation and fundamentals.
Community discussion

Comments

Share a useful question or insight about Corona Remedies.

Loading comments...

Leave a comment

Your email address will not be published. All comments and replies are reviewed before appearing.

Keep Exploring

Similar Recent IPOs

Related Topics
Corona Remedies IPOCorona Remedies GMPCorona Remedies IPO GMPCorona Remedies IPO GMP todayCorona Remedies grey market premiumCorona Remedies price bandCorona Remedies subscription statusCorona Remedies allotment statusCorona Remedies listing dateCorona Remedies lot sizeCorona Remedies IPO reviewCorona Remedies IPO listing gain estimateCorona Remedies GMP calculatorCorona Remedies IPO 2025